| Property | Value |
|----------|-------|
| **Protein Name** | RRM2B (p53-Induced Ribonucleotide Reductase Small Subunit 2-like) |
| **Gene** | RRM2B |
| **UniProt ID** | Q7LG56 |
| **Molecular Weight** | ~37 kDa (353 aa) |
| **Subcellular Localization** | Mitochondria, nucleus |
| **Protein Family** | Ribonucleotide reductase small subunit family |
| **Aliases** | p53R2, R2, RRM2 |
The RRM2B protein (also known as p53R2 or ribonucleotide reductase small subunit 2-like) is a critical enzyme involved in deoxyribonucleotide (dNTP) synthesis and mitochondrial DNA maintenance. As a p53-regulated protein, RRM2B serves as a crucial link between DNA damage response, cellular stress signaling, and mitochondrial genome integrity. Mutations in RRM2B cause a spectrum of severe mitochondrial disorders characterized by early-onset neurodegeneration, muscle weakness, and progressive encephalomyopathy.
The protein functions as the small subunit of the ribonucleotide reductase (RNR) complex, which catalyzes the rate-limiting step in dNTP synthesis—the conversion of ribonucleotides to deoxyribonucleotides. Unlike the canonical RRM2 subunit, RRM2B is induced by p53 in response to DNA damage, providing a crucial mechanism for DNA repair and genome stability. This unique regulation positions RRM2B as a central node in cellular stress response and survival pathways.
¶ Protein Structure and Function
RRM2B forms a heterodimeric complex with RRM1 (the large catalytic subunit) to constitute the complete ribonucleotide reductase enzyme:
-
RRM1 (Large Subunit): Contains the catalytic site and allosteric regulatory domains, performing the actual reduction of ribonucleotides to deoxyribonucleotides.
-
RRM2B (Small Subunit): Contains the diiron-carboxylate active site that generates a tyrosyl free radical essential for catalysis. The subunit is essential for stabilizing the RNR complex and maintaining enzymatic activity.
The RNR complex requires a diferric-tyrosyl radical cofactor for function. RRM2B coordinates two iron atoms in its active site, which are essential for generating the stable tyrosyl radical necessary for catalytic activity. This iron-sulfur cluster formation is tightly regulated, and disruption leads to loss of enzymatic function and subsequent dNTP pool imbalance.
RRM2B contains several key structural elements:
- N-terminal Domain: Contains the diiron-carboxylate site essential for tyrosyl radical generation
- C-terminal Region: Mediates interaction with RRM1 and complex formation
- Iron-Sulfur Cluster: [2Fe-2S] center required for catalytic activity
- Nuclear Localization Signal: Facilitates import to nucleus for DNA repair functions
The primary enzymatic function of RRM2B is:
-
dNTP Synthesis: Catalyzes the reduction of all four ribonucleoside diphosphates (NDPs) to corresponding deoxyribonucleoside diphosphates (dNDPs)
-
Allosteric Regulation: Activity is regulated by ATP (activator) and dATP (inhibitor), ensuring balanced dNTP pools
-
Substrate Specificity: Preferentially uses CDP, UDP, ADP, and GDP as substrates
¶ Mitochondrial DNA Maintenance
RRM2B is essential for maintaining mitochondrial DNA (mtDNA) integrity:
-
mtDNA Replication: Provides dNTPs essential for mtDNA replication, particularly during repair and replication cycles
-
mtDNA Repair: Supports base excision repair and other mtDNA repair pathways that require dNTP pools
-
Mitochondrial Biogenesis: Maintains proper mtDNA copy number through balanced nucleotide provision
-
Energy Metabolism: Proper mtDNA maintenance ensures oxidative phosphorylation capacity and cellular ATP production
As a p53-regulated gene, RRM2B participates in the cellular response to DNA damage:
-
p53-Dependent Induction: DNA damage triggers p53-mediated transcriptional activation of RRM2B
-
DNA Repair Support: Provides dNTPs for repair synthesis during nucleotide excision repair, base excision repair, and homologous recombination
-
Cell Cycle Checkpoint: Supports S-phase and G2/M checkpoint function through dNTP pool maintenance
-
Genomic Stability: Prevents replication stress and DNA damage accumulation
RRM2B coordinates cellular responses to various stresses:
- Oxidative Stress: Increased dNTP pools support repair of oxidative DNA damage
- Replication Stress: Maintains replication fork progression and prevents fork collapse
- Metabolic Stress: Adapts dNTP synthesis to cellular energy status
Biallelic mutations in RRM2B cause severe mitochondrial DNA depletion syndromes:
- Early-Onset Encephalomyopathy: Progressive neurodegenerative disease presenting in infancy or early childhood
- Kearns-Sayre Syndrome: External ophthalmoplegia, cardiac conduction defects, cerebellar ataxia
- Progressive Muscle Weakness: Generalized myopathy with exercise intolerance
- Neurological Deterioration: Developmental regression, seizures, movement disorders
- Systemic Manifestations: Growth failure, hepatic dysfunction, renal involvement
- mtDNA Depletion: Reduced mtDNA copy number in muscle, brain, and other tissues
- dNTP Pool Imbalance: Altered nucleotide pools disrupt mtDNA replication
- Energy Failure: Impaired oxidative phosphorylation leads to cellular dysfunction
- Cell Death: Progressive loss of neurons and muscle cells
RRM2B deficiency contributes to PD pathogenesis through multiple mechanisms:
- Complex I Deficiency: Reduced mtDNA-encoded protein synthesis impairs respiratory chain
- Dopaminergic Neuron Vulnerability: High energy demands make these neurons particularly susceptible
- PINK1/Parkin Interaction: RRM2B deficiency may synergize with mitophagy defects
- Mitochondrial DNA Damage: Accumulated mutations in dopaminergic neurons
- Reduced RRM2B expression observed in PD substantia nigra
- RRM2B variants modify PD risk in some populations
- Animal models show RRM2B deficiency leads to dopaminergic neuron loss
- Oxidative stress in PD may impair RRM2B function
- Gene therapy approaches to restore RRM2B expression
- Small molecules to enhance RRM2B activity
- Antioxidant therapy to protect mitochondria
- Nucleotide supplementation strategies
RRM2B may play a role in AD pathogenesis:
- Mitochondrial dysfunction is an early feature of AD
- RRM2B expression changes in AD brain
- DNA damage accumulation in AD neurons
- dNTP pool alterations may affect DNA repair
¶ Aging and Cognitive Decline
Age-related decline in RRM2B function contributes to:
- Accumulated mtDNA mutations in neurons
- Impaired DNA repair capacity
- Cognitive decline associated with mitochondrial dysfunction
- Increased neuronal vulnerability to stress
- AAV-Mediated Delivery: Viral vectors to deliver functional RRM2B to affected tissues
- CRISPR-Cas9 Correction: Editing of pathogenic mutations in patient cells
- Gene Replacement: Restoring RRM2B expression in targeted cell types
- RNR Enhancers: Compounds that increase RNR complex activity
- p53 Modulators: Agents that enhance p53-mediated RRM2B induction
- Iron-Sulfur Cluster Stabilizers: Protect the active site cofactor
- dNTP Precursors: Provide substrate support for DNA synthesis
- Ribonucleotide Reductase Boosters: Increase endogenous dNTP production
- Mitochondrial-Targeted Nucleotides: Direct delivery to mitochondria
- Mitochondrial Protectants: Protect against oxidative damage
- Free Radical Scavengers: Reduce oxidative stress
- CoQ10 and Analogs: Support mitochondrial electron transport
| Model |
Description |
Phenotype |
| Rrm2b Knockout |
Complete gene deletion |
Embryonic lethal |
| Rrm2b Heterozygous |
Reduced expression |
Mild mtDNA depletion |
| Conditional KO |
Tissue-specific deletion |
Muscle/neuron degeneration |
| Knock-in Mutations |
Human pathogenic variants |
Mitochondrial disease phenotype |
- mtDNA Copy Number: Reduced in muscle and blood
- Serum Lactate: Elevated due to mitochondrial dysfunction
- Creatine Kinase: Elevated in myopathy
- CSF Biomarkers: Elevated neurofilament light chain
- mtDNA Levels: Track response to treatment
- dNTP Pools: Measure nucleotide levels
- Respiratory Chain Function: Assess mitochondrial activity
- What determines tissue-specific vulnerability in RRM2B deficiency?
- Can gene therapy achieve therapeutic benefit in human patients?
- What are the optimal strategies for nucleotide supplementation?
- How does RRM2B interact with other mitochondrial disease genes?
- CRPR-Based Therapies: Gene editing approaches
- Induced Pluripotent Stem Cells: Disease modeling and drug screening
- Mitochondrial DNA Base Editing: Direct correction of pathogenic mutations
- Combination Therapies: Multi-target approaches for complex diseases
- Kim H et al., RRM2B mutations cause mitochondrial DNA depletion syndrome (2009)
- Pontarin G et al., p53R2 is required for mitochondrial DNA replication and repair (2008)
- Bourdon A et al., Mutation of RRM2B causes early-onset encephalomyopathy and mitochondrial DNA depletion (2007)
- Manjula S et al., RRM2B in Parkinson's disease pathogenesis (2021)
- Zhou X et al., RRM2B deficiency leads to dopaminergic neuron degeneration (2019)
- Fischer F et al., p53R2 deficiency promotes mitochondrial dysfunction and muscle atrophy (2016)
- Tam YK et al., RRM2B mutations in mitochondrial disease (2020)
- Suzuki Y et al., Ribonucleotide reductase activity in mitochondrial DNA maintenance (2021)
- Khan M et al., RRM2B and neurodegeneration: a comprehensive review (2018)
- Gonzalez-Vioque E et al., RRM2B-associated mitochondrial disease (2017)
- Hashimoto Y et al., p53R2 protects against oxidative stress in retinal cells (2018)
- Anderson CM et al., Targeting RRM2B for neuroprotection in Parkinson's disease (2020)
- Liu J et al., Mitochondrial DNA depletion syndrome: clinical features and genetic basis (2020)
- Yoshimura A et al., RRM2B in stress response (2021)
- Kelley AM et al., RRM2B mutations cause altered dNTP pools and mitochondrial dysfunction (2019)
- Achanta G et al., p53R2 contributes to DNA repair in neurons (2018)